Utah’s business landscape is rich with professionals who have le...Read More
Social Media and Employers: Friends or Enemies?
The Case for HSAs
Time to Show Up
Make a Move
In the Lab
Rent to Own
Back from the Dead
A Breath of Fresh Air
Travel & Tourism
Salt Lake City — Amedica Corporation, a biomaterial company based in Salt Lake City, has entered into a distribution agreement with K2M that will provide surgeons and hospitals in Europe with access to Amedica's Silicon Nitride interbody spinal fusion devices. K2M is the largest privately-held spinal device company in the world.
Earlier this year, Amedica and K2M conducted a pilot program in select markets in Europe where surgeons were provided the opportunity to integrate Silicon Nitride interbody devices into their offerings for patients suffering from a variety of disorders requiring spinal fusion. This pilot program demonstrated a need in these strategic markets for spinal fusion devices devised from a different biomaterial.
"K2M has an outstanding sales and marketing team that has created a global reputation for providing leading edge technology to their customers,” said Eric K. Olson, president and CEO of Amedica.